Virology News and Research

Latest Virology News and Research

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

UF researchers play integral role in Ebola vaccine trial

An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.

26 Dec 2016

Slayback Pharma launches Generic Zovirax Ointment 5% for herpes virus infections

Slayback Pharma LLC is pleased to announce the launch of Generic Zovirax Ointment (Acyclovir Ointment) 5%, by its out-licensee - Sandoz (Fougera). Slayback had developed the product and out-licensed the sales and marketing rights to Sandoz.

23 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.

23 Dec 2016

Genomic sequencing reveals new insights into major shigellosis outbreaks in California

In a study that could have significant impact on how disease outbreaks are managed, researchers at UC Davis and the California Department of Public Health have sequenced and analyzed genomes from Shigella sonnei (S. sonnei) bacteria associated with major shigellosis outbreaks in California in 2014 and 2015.

23 Dec 2016

Blocking protein that initiates immune response against viral infections may help combat HIV

In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.

23 Dec 2016

TSRI scientists shed light on how antiviral drug stops influenza infections

A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus.

22 Dec 2016

Mount Sinai researchers laying groundwork to find effective treatment for Zika virus

Researchers at the Icahn School of Medicine at Mount Sinai are working on the basic science that lays the groundwork to finding a way to treat and prevent the Zika virus, a global health risk.

22 Dec 2016

Heart attack risk for people with HIV nearly 50% higher than predicted

Current methods to predict the risk of heart attack and stroke vastly underestimate the risk in individuals with HIV, which is nearly double that of the general population, reports a new Northwestern Medicine study.

21 Dec 2016

Researchers engineer promising live-attenuated RSV vaccine candidate

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

21 Dec 2016

USPSTF recommends against routine serologic screening for genital HSV infection

The U.S. Preventive Services Task Force recommends against routine serologic screening (via a blood test) for genital herpes simplex virus infection in asymptomatic adolescents and adults, including those who are pregnant.

20 Dec 2016

Study compares medications for treatment of persons with recurrent genital herpes

In a study appearing in the December 20 issue of JAMA, Anna Wald, M.D., M.P.H., of the University of Washington & Fred Hutchinson Cancer Research Center, Seattle, and colleagues compared the medications pritelivir and valacyclovir for reducing genital herpes simplex virus shedding and lesions in persons with recurrent genital herpes.

20 Dec 2016

Virology News and Research

Latest Virology News and Research

New study shows efficacy of Ebola vaccine in offering protection against disease

UF researchers play integral role in Ebola vaccine trial

Slayback Pharma launches Generic Zovirax Ointment 5% for herpes virus infections

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Genomic sequencing reveals new insights into major shigellosis outbreaks in California

Blocking protein that initiates immune response against viral infections may help combat HIV

TSRI scientists shed light on how antiviral drug stops influenza infections

Mount Sinai researchers laying groundwork to find effective treatment for Zika virus

Heart attack risk for people with HIV nearly 50% higher than predicted

Researchers engineer promising live-attenuated RSV vaccine candidate

USPSTF recommends against routine serologic screening for genital HSV infection

Study compares medications for treatment of persons with recurrent genital herpes

Texas A&M specialist explains what people need to know about mumps

Genetic mutation may increase susceptibility to cytomegalovirus infection

Texas A&M professor shares tips to protect infants from RSV

Scientists develop safe, effective vaccine for chikungunya fever from insect-specific virus

Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Scientists develop novel nanoparticle-based method to deliver DNA vaccine

NIH-funded scientists work with three ‘omes’ to understand human health

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows